Samreen Ahmed
Overview
Explore the profile of Samreen Ahmed including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
990
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Derksen J, Warren G, Jordan K, Rauh S, Garcia R, OMahony D, et al.
Eur J Cancer
. 2020 Sep;
138:99-108.
PMID: 32871527
Background: Smoking cessation after a cancer diagnosis is associated with improved overall survival. Few studies have reported oncologists' cessation practice patterns, but differences between the curative and palliative settings have...
22.
Robertson J, Coleman R, Cheung K, Evans A, Holcombe C, Skene A, et al.
Clin Cancer Res
. 2019 Dec;
26(7):1574-1585.
PMID: 31836609
Purpose: The STAKT study examined short-term exposure (4.5 days) to the oral selective pan-AKT inhibitor capivasertib (AZD5363) to determine if this drug can reach its therapeutic target in sufficient concentration...
23.
Reck M, Schenker M, Lee K, Provencio M, Nishio M, Lesniewski-Kmak K, et al.
Eur J Cancer
. 2019 Jun;
116:137-147.
PMID: 31195357
Background: In the phase III CheckMate 227 study, first-line nivolumab + ipilimumab significantly prolonged progression-free survival (co-primary end-point) versus chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC) and high...
24.
Coombes R, Page K, Salari R, Hastings R, Armstrong A, Ahmed S, et al.
Clin Cancer Res
. 2019 Apr;
25(14):4255-4263.
PMID: 30992300
Purpose: Up to 30% of patients with breast cancer relapse after primary treatment. There are no sensitive and reliable tests to monitor these patients and detect distant metastases before overt...
25.
Gokal K, Munir F, Ahmed S, Kancherla K, Wallis D
PLoS One
. 2018 Nov;
13(11):e0206874.
PMID: 30485297
Background: Cancer related cognitive impairments have been subjectively reported and objectively detected in breast cancer patients treated with chemotherapy and are known to have a profound negative impact on productivity,...
26.
Arlt M, Rajendran S, Holmes S, Wang K, Bergin I, Ahmed S, et al.
Environ Mol Mutagen
. 2018 Sep;
59(8):698-714.
PMID: 30218578
Copy number variants (CNVs) are important in genome variation and genetic disease, with new mutations arising frequently in the germline and somatic cells. Replication stress caused by aphidicolin and hydroxyurea...
27.
Wilson G, Johnson M, Ahmed S, Cardenas P, Grills I, Thibodeau B
Oncotarget
. 2018 Jun;
9(40):25957-25970.
PMID: 29899834
Introduction: This study explores the hypothesis that dominant molecular oncogenes in non-small cell lung cancer (NSCLC) are associated with metastatic spread to the brain. Methods: NSCLC patient groups with no...
28.
Thibodeau B, Lavergne V, Dekhne N, Benitez P, Amin M, Ahmed S, et al.
Oncotarget
. 2018 Mar;
9(11):10042-10053.
PMID: 29515789
Purpose: Radiation-associated breast angiosarcomas are a rare complication of radiation therapy for breast carcinoma. With relatively little is known about the genetic abnormalities present in these secondary tumors, we examined...
29.
Tonlaar N, Galoforo S, Thibodeau B, Ahmed S, Wilson T, Cardenas P, et al.
Radiother Oncol
. 2017 Aug;
124(3):504-512.
PMID: 28823407
Background And Purpose: Head and neck squamous cell carcinoma (HNSCC) remains a clinical challenge where new treatments are required to supplement the current-standard-of care of concurrent chemoradiation. The PI3K/AKT/MTOR pathway...
30.
Ciuleanu T, Ahmed S, Kim J, Mezger J, Park K, Thomas M, et al.
Br J Cancer
. 2017 Aug;
117(6):757-766.
PMID: 28772281
Background: Maintenance therapy is important in advanced/metastatic non-small cell lung cancer (NSCLC). Erlotinib as switch maintenance following platinum-based chemotherapy increases survival. Cross-talk between the epidermal growth factor receptor and insulin-like...